FDA, COVID-19 vaccine
Digest more
Top News
Overview
Impacts
The Food and Drug Administration will issue new guidelines requiring stiffer clinical trials prior to the approval of new COVID boosters.
The United States, traditionally the top donor to the UN health agency, was not part of the final stages of pandemic agreement process after the Trump administration announced a pullout from the WHO.
Leaders at the FDA, HHS and elsewhere are putting guardrails around COVID-19 boosters, which could mean delayed shots or eligibility changes this fall.
WHO members on Tuesday adopted a treaty that outlines how to prepare for and respond to pandemics. One country missing: the U.S.
8d
News-Medical.Net on MSNNew AI tool predicts viral mutations to help future-proof COVID vaccinesA novel AI-driven method helps scientists stay ahead of viral evolution by engineering synthetic spike proteins that anticipate future SARS-CoV-2 escape mutations, offering a powerful tool to test and strengthen next-generation vaccines.
The World Health Organization's member countries have approved an agreement to better prevent, prepare for and respond to future pandemics in the wake of the devastation wrought by the coronavirus.
By Kamal Choudhury (Reuters) -Novavax shares jumped more than 15% on Monday after the company secured a long-awaited U.S. regulatory approval for its COVID-19 vaccine, albeit with new conditions, which helped allay some investor concerns over the future of the shot.
Since the COVID-19 pandemic, there has been a decline in U.S. vaccine uptake, while widespread misinformation and distrust make it challenging to craft effective public health responses.